Cells of the Epstein-Barr virus (EBV) non-producing lines NC37 and Raji were induced by the turnout promoter TPA and were labelled with 3~p. The analysis by immunoprecipitation with human VCA+EA + sera revealed that a major phosphopolypeptide with a mol. wt. of 58000 was specifically precipitated. In addition, a phosphopolypeptide of the same size was the dominant phosphopolypeptide detected in EBV-producing B95-8 and P3HR-1 cells as well as in P3HR-l-superinfected NC37 cells. This phosphopolypeptide seemed to be EBV-specific, because it was not detectable in TPA-treated, but EBV genome-negative, Ramos and B JAB cells. Synthesis of this phosphopolypeptide was inhibited in TPA-treated NC37 cells by treatment with Ara-C. VCA+EA + sera were found to be more immunoreactive with this phosphopolypeptide than VCA+EA -or EBNA + sera. Based on these results this phosphopolypeptide may have some immunological relatedness to the EBV-specific early antigen (EA) complex defined by immunofluorescence.
INTRODUCTION
Epstein-Barr virus (EBV) causes infectious mononucleosis (Henle & Henle, 1974) and has also been associated with two human malignant turnouts, Burkitt's lymphoma and nasopharyngeal carcinoma (Klein, 1973; Henle & Henle, 1974; zur Hausen, 1975) . Various EBV-related antigens have been differentiated by immunofluorescence techniques in continuous lymphoblastoid cell lines harbouring EBV genomes. In virus-producing lines a small percentage of cells synthesize viral antigens, which are associated with early (Henle et al., 1970) or late functions of the viral genome (zur Hausen et al., 1967) .
The synthesis of early antigens (EA) can be induced in non-producer cells by superinfection with EB virus isolated from the P3HR-I line, and takes place before onset of viral DNA replication (Henle et al., 1970) . Two different types of EA have been described by differential fixation procedures of the cells: the diffuse type (EA-D) and the restricted type (EA-R) (Henle et al., 1971) . EA can also be induced chemically by treatment with the base analogues bromodeoxyuridine and iododeoxyuridine (Gerber, 1972; Hampar et al., 1972; Sugawara et al., 1972) , with tumour promoters (zur Hausen et al., 1978 , in IgM-producing cells with antibodies to human IgM (Tovey et al., 1978) and, as recently demonstrated, with n-butyric acid (Luka et aI., 1979) .
Recent reports demonstrated that induction of the non-producer lines NC37 and Raji resulted in EA synthesis only (zur Hausen et al., 1978) . In the NC37 line 15 to 25 % of the cells were EA-positive, while in specific clones of Raji cells 30 to 80% of the cells exhibit EA fluorescence (Bister et al., 1979) .
It was reported recently that in tumour promoter TPA-induced Raji cells as well as in NC37 cells two [35S] methionine-labeUed early EBV-associated polypeptides with mol. wt. of 85000 and 35000 could be identified (Mueller-Lantzsch et al., 1979) . Furthermore, other findings demonstrated that in superinfected Raji cells, at least two classes of virus-induced proteins could be recognized (Bayliss & Nonoyama, 1978) . One class, induced in the absence of DNA synthesis, contained three polypeptides with molecular wt. of 120000, 90000 and 35000 respectively. The synthesis of a second class was greatly reduced under conditions of inhibition of viral DNA replication.
Investigation of polypeptides from other members of the herpesvirus group like HSV 1 and HSV2 indicate that in these systems two immediate early polypeptides (Pereira et al., 1977) and in total 15 to 17 virus-induced polypeptides were phosphorylated (Marsden et al., 1978) . By analogy with the results obtained with these members of the herpesvirus group, it might be expected that some identified early EBV-induced polypeptides or other, as yet unidentified early EBV-associated polypeptides, are phosphorylated. We have attempted to identify and analyse phosphorylated EBV-induced polypeptides by immunoprecipitation. 32p-labelled cell extracts from TPA-stimulated non-producer cell lines NC37 or from P3HR-1 EBV superinfected NC37 cells were incubated with several VCA+EA -or VCA+EA -human sera. The precipitates were analysed by SDS-polyacrylamide gel electrophoresis (PAGE) followed by autoradiography.
METHODS

Cells and virus.
The origin and maintenance of non-producer NC37 cells, EBV-producing P3HR-1 cells as well as EBV genome-negative Ramos cells are described elsewhere (Fresen & zur Hausen, 1976) . All cell lines were maintained in RPMI 1640 medium (Flow Laboratories) supplemented with 10% foetal calf serum, penicillin (100 international units/ml) and streptomycin (100 gg/ml). They were subcultured routinely once or twice weekly. Procedures for the production of EBV were described previously (Mueller-Lantzsch et al., 1979) . Conditions for the activation of the resident genome in NC37 non-producer cells as well as in P3HR-1 EBV-producing cells by the tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) have been described previously (zur Hausen et al., 1978 . Briefly, TPA (kindly provided by Professor E. Hecker, Heidelberg or obtained commercially from Sigma) was dissolved in dimethyl sulphoxide and added to the tissue culture medium at a concentration of 20 ng/ml.
Immunofluorescence. EA and VCA induction was assayed by indirect immunofluorescence as described previously (zur Hausen et al., 1967 (zur Hausen et al., , 1978 Fresen & zur Hausen, 1976) .
Procedure for virus infection. NC37 cells were mixed with P3HR-1 EB virus to give a final concentration of approx. 5 × 106 cells/ml and incubated at 37 °C for 72 h. Two days after infection about 30 to 40% of the infected cells were EA-positive while 15 to 20% of the cells were showing a VCA-positive immunofluorescence.
Labelling of proteins. Labelling of viral antigens with [35S]methionine was performed by incubating 5 x 106 virus-producing P3HR-1 cells at day 4 after TPA addition for 4 h in 0-5 ml medium lacking methionine and containing between 100 and 200 pCi [35S]methionine (sp. act. 800 to 1000 Ci/mmol/ml) and 5 % foetal calf serum. After labelling, the cell suspension was washed thoroughly 3 times in PBS and then lysed by adding 1-5 ml cold extraction buffer (0.14 M-NaC1; 3 mM-MgC12; 1 mM-dithiothreitol; 2 mM-phenylmethylsulphonyl fluoride (PMSF); 10 mM-tris-HC1 pH 8 containing 0.5 Nonidet P40 (NP40). The lysates were further fractionated, after vortexing and incubating for 20 min on ice, by centrifugation at 4000 g for 20 min at 4 °C into a NP40-soluble 'cellular extract'. Labelling of NC37 cells with 32p was performed in the same fashion as described for [35S]methionine-labelled cells, with the following exception: cells (5 × 106) were labelled for 4 h with 1 mCi 3Zp/ml in medium containing only one-tenth of the regular amount of phosphate. 
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Immunopreeipitation. To precipitate viral immunoreactive proteins, the soluble extracts containing 4 x 106 ct/min 35S or 10 x 106 ct/min 32p were cleared by centrifugation for 2 min at 12000 g and were first incubated with human VCA-EA-EBNA-serum (referred to as negative human control serum) for 16 h at 0 °C at a ratio of 30 gl serum per 100 gl extract. The IgG molecules of this serum were removed by adding 200 gl of the inactivated Staphylococcus aureus (10%, w/w) suspension and pelleting of the resulting complex after incubation as described previously (Kessler, 1975; Mueller-Lantzsch et al., 1979) . This procedure was essential to reduce an excess of non-specific precipitating material. The supernatant was then incubated for 4 h at 4 °C with 30 gl specific antiserum which had a VCA titre of 1 : 1024, and ranging EA titre between 1:256 and 1:1024 as judged by indirect immunofluorescence.
After further incubation with 200 pl of the S. aureus suspension for 20 rain at 0 °C the bacteria were pelleted at 12000 g for 2 min, washed twice with 30% sucrose in washing buffer (20 mM-tris-HC1 pH 7.6; 0-5 M-NaC1; 1 mM-EDTA; 0.5% NP40 and 1% desoxycholate) and finally twice with a buffer containing 10 mM-tris-HCl pH 7.6 and 10 mM-NaCI. The antigen-antibody-bacteria complex was resuspended in 70 gl of electrophoresis sample buffer (0.0625 u-tris-HC1 pH 6.8; 2% SDS; 4% mercaptoethanol; 10% glycerol and 0.05% bromophenol blue) and 10 #1 or 15 gl samples per slot were applied on the analytical SDSpolyacrylamide gel.
Polyaerylamide gel eleetrophoresis (PAGE). Electrophoresis in SDS-polyacrylamide slab
gels was performed in a 7.5 % separating gel with 5 % stacking gel using the discontinuous buffer system of Laemmli (1930) at a constant current of 12.5 mA as described previously (Mueller-Lantzsch & Fan, 1976) . For autoradiography of gels containing 32p-labelled material, an intensifying screen Cronex (Du Pont) was used. For analysing [35S]methionine-labelled material the gels were prepared for fluorography as described by Bonnet & Laskey (1974) . E. eoli RNA polymerase (150000 and 160000), phosphorylase A (94000), serum albumin (68000), ovalbumin (43 000), chymotrypsinogen (25 000) and cytochrome c (12000) served as markers for tool. wt. determinations.
RESULTS
Phosphorylation of EB V-induced polypeptides
In this study we have attempted to identify phosphorylated EBV-induced polypeptides. NC37 and Raji cells were stimulated by TPA and were labelled at 4 days after induction with 32p. At this time maximum synthesis of [35S]methionine-labelled early EBV-induced polypeptides occurs (Mueller-Lantzsch et al., 1979) . Cells were washed and lysed.
Immunoprecipitations were performed by using several VCA+EA +, VCA+EA -and negative control sera as described elsewhere (Mueller-Lantzsch et al., 1979) . A representative result is shown in Fig. 1 . It could be demonstrated that a phosphopolypeptide was specifically precipitated from TPA-induced NC37 cells by using VCA+EA + sera. This phosphopolypeptide which was estimated to be about 58000 in mol. wt. was designated as pp58. A similar result was obtained when TPA-stimulated Raji cells were analysed. This phosphopolypeptide was neither detectable in non-stimulated NC37 cells (Fig. 1 a) nor in EBV genome-negative Ramos and B JAB cells (Fig. 5 ) nor by using a negative control serum (Fig.  1 b) . All VCA+EA + sera tested so far (15 sera), reacted very strongly with pp58 regardless of whether the sera were EBNA + or EBNA-. On the other hand, some but not all of the VCA + but EA-sera tested (15 sera) showed a positive, although weak reaction with pp58. A representative result is demonstrated in Fig. 1 (i) . All human EBV-negative control sera (15 sera) tested so far were negative in this assay (data not shown). The phosphopolypeptide was also precipitated when defined anti EA-D and EA-R sera were used for immunoprecipitation (data not shown). When 32p-labelled virus-producing cells like P3HR-1 or B95-8 were analysed 4 days after TPA application, a phosphopolypeptide, indistinguishable in size from pp58, was the dominant phosphopolypeptide precipitated from these cells as shown for B95-8 cells in Fig. 2 . In addition, 32p-labeUed material of about 50 000 to 55 000 co-migrates with the heavy chains of the IgG molecules. This effect was reproducibly observed only when extracts from cells containing the EBV genome and treated with TPA were immunoprecipitated by using EA + sera. At the present time it is not clear whether this radioactive material represents a distinct new polypeptide or reflects an artefact due to our procedure. Furthermore, a series of phosphorylated polypeptides, present only in trace amounts, with mol. wt. of approx. 40000, 60000 to 70000, 85 000 and more could be observed. None of these polypeptides was precipitated by EBV-negative sera or from extracts of TPA-untreated cells. At present we have no information whether these polypeptides belong to the EA or VCA complex.
Comparison of [ 32P] and [ 35 S ]methionine-labelled EB V-associated polypeptides
The rate of synthesis of TPA-induced, EBV-associated polypeptides was studied next. TPA-induced NC37 cells were labelled at different times after induction in parallel with [32p] and [35S]methionine. NP40-soluble cell extracts were immunoprecipitated by using a VCA+EA + human serum. The percentage of EA-positive cells were monitored in parallel by immunofluorescence. The data indicate (not shown) that from day 1 to day 4 the number of EA-positive cells increased almost linearly, reaching a maximum of about 25 % at day 4.
When 32P-labelled cells were investigated (Fig. 3) , pp58 was found to be maximally synthesized 4 days after the onset of TPA treatment. Immunoprecipitation of an EB V phosphoprotein 3 3 7 polypeptide of similar size as pp58 could be detected which was maximally produced 2 days after T P A induction. At day 3 and 4 the synthesis of this polypeptide decreased r e m a r k a b l y while two other polypeptides, p85 and p35 already identified as early EBV-associated Immunoprecipitation of an EB V phosphoprotein 339 polypeptides (Mueller-Lantzsch et al., 1979) , were synthesized in almost constant amounts. It should be noted that the background of non-specific precipitated material in this experiment was slightly higher than found previously. These data indicate that two polypeptides of the same size can be precipitated from TPA-induced NC37 cells, a phospho-and a non-phosphopolypeptide. At the present time we have no information as to whether these two polypeptides are related or not.
Analysis of P3HR-1 EB V-superinfeeted NC37 cells
In additional experiments P3HR-l-superinfected NC37 cells were labelled with 3zp at 24 and 48 h after infection. The immunoprecipitations demonstrated (Fig. 4) that a phosphopolypeptide of a similar size to pp58 could be detected which was maximally synthesized at 48 h. Addition of Ara-C (20 ag/ml) greatly reduced the synthesis of this phosphoprotein (Fig. 4 e, f) , while under the same conditions the synthesis of a series of [35S]methionine-labelled EBV-associated polypeptides, including a 58 000 polypeptide and the early p85 and p35, was not affected (Mueller-Lantzsch et al., 1980) . No phosphopolypeptide could be identified when cells were treated with cycloheximide (50/2g/ml) (Fig. 4d, g) .
A similar inhibition of synthesis of the phosphopolypeptide pp58 by Ara-C could be detected when TPA-treated NC37 cells were analysed (Fig. 5) . The application of Ara-C reduces the synthesis of pp58 remarkably while under the same conditions no reduction of either EA-positive fluorescence nor inhibition of the EA-associated polypeptides p85 and p35 was observed (N. Mueller-Lantzsch & N. Yamamoto, unpublished results) .
DISCUSSION
This work focussed on further biochemical characterization of EBV-associated polypeptides. Immunoprecipitation of NP40 soluble cell extracts from 3ZP-labelled, TPA-induced, EBV non-producer NC37 and Raji cells as well as from EBV-producing P3HR-1 and B95-8 cells with VCA+EA +, VCA-EA-and negative control sera resulted in a significant precipitation of dominant phosphopolypeptides with tool. wt. of 58 000 (pp58). On the other hand, no pp58 could be detected in EBV genome-negative Ramos and B JAB cells regardless of whether they were treated with TPA or not, or in non-stimulated EBV non-producer NC37 and Raji cell lines. These results indicate that the phosphopolypeptide pp58 is EBV-specific.
Based on the specific interaction with VCA+EA + sera and on the mol. wt. we conclude from these results that the phosphopolypeptides of 58 000 mol. wt. from TPA-induced NC37 cells, P3HR-1 superinfected NC37 cells as well as from EBV-producing cells are identical, although this has not been proved.
There is a striking correlation between high anti-EA titres and strong reactivity against pp58. Some VCA ÷ but EA-sera exhibited a moderately positive reaction with pp58. At the present time we do not know whether this is due to a low anti EA-reactivity not detected in the sera despite testing for EA reactivity by indirect immunofluorescence starting at dilutions of 1 : 8. In addition, some sera which were EBNA-in anti-complementary immunofluorescence reacted highly positively with pp58, suggesting that pp58 has no relation to the EBNA complex.
In P3HR-1-superinfected NC37 cells as well as in TPA-induced NC37 cells the amount of pp58 was strongly reduced after treatment of the cells with Ara-C, although we have no information as to whether Ara-C affects the synthesis or the phosphorylation of pp58. On the other hand, no reduction of EA-positive cells could be observed in immunofluorescence tests nor was the synthesis of the EA-associated polypeptides p85 and p35 affected. These data clearly indicate that the phosphopolypeptide pp58 and the early polypeptides p85 and p35 belong to different classes of EBV-associated polypeptides. It is not possible to decide whether N. MUELLER-LANTZSCH AND N. YAMAMOTO pp58 is part of the EBV-associated EA complex or not. The correlation of high anti-EA titres and strong reactivity against pp58 revealed some immunological relatedness, but we cannot rule out the possibility that an unknown EBV-specific immunological activity in these sera, different from EA, precipitates pp58. At present, we do not know whether the EBV-specific pp58 is virus-or host-coded. Comparable data are reported from other viral systems. A cellular phosphoprotein of 54000 mol. wt. was stimulated by SV40 infection and transformation in mouse or hamster cells (Linzer & Levine, 1979) . This protein is associated with SV40 T antigen and presumably aggregates with immunoprecipitated SV40 T antigen. Our results are in some agreement with a recent report (Feighny et al., 1980) in which the appearance of phosphoproteins in Raji cells superinfected by a high multiplicity of P3HR-1 virus was investigated. The existence of at least seven EBV-induced phosphopolypeptides was demonstrated directly without using immunoprecipitation methods. One of the most actively synthesized phosphopolypeptides was a polypeptide of 52000 mol. wt. (22P). It is possible that this 22P phosphopolypeptide may correspond to the phosphopolypeptide pp58, the differences in mol. wt. being due to technical procedures.
Recently the existence of an EBNA-associated 53K polypeptide was reported (Luka et al., 1980) . Since some EBNA-sera reacted strongly with pp58 it is most likely that this polypeptide is different from the 53K polypeptide. Furthermore, no 53K phosphopolypeptide could be identified in TPA-untreated NC37 cell extracts by using highly EBNA + sera (data not shown).
Further studies are necessary to understand the immunological relationship of the non-phosphopolypeptide p58 and phosphopolypeptide pp58. In another investigation two cellular proteins with mol. wt. of approx. 58 000 are reported which are associated with virus or spontaneous transformation of mammalian cells and which are secreted into the supernatants (Senger et al., 1979) . Both proteins, a non-phosphoprotein and a phosphoprotein, seemed to be cell species-specific, but are unrelated to each other. No data are available on a possible relationship between these polypeptides and the EBV-specific pp58 and the non-phosphopolypeptide p58 reported in this study.
